What is New Phase Research & Development?
Based in Knoxville, Tennessee, New Phase Research & Development operates as a specialized clinical research organization with over 14 years of industry experience. The company distinguishes itself through a rigorous approach to trial selection and participant management, ensuring high-quality data output for pharmaceutical sponsors. By maintaining a highly educated staff and a secure, patient-focused environment, the firm bridges the gap between complex medical research requirements and the practical realities of clinical trial enrollment. Their market position is defined by a commitment to operational excellence and a proven track record in facilitating successful, high-performance research outcomes.
How much funding has New Phase Research & Development raised?
New Phase Research & Development has raised a total of $106K across 1 funding round:
Debt
$106K
Debt (2021): $106K with participation from PPP
Key Investors in New Phase Research & Development
PPP
Public-Private Partnership
What's next for New Phase Research & Development?
With this recent infusion of capital, New Phase Research & Development is poised to accelerate its strategic growth initiatives. The firm is expected to leverage these resources to expand its clinical trial portfolio and deepen its collaborative relationships with global pharmaceutical entities. By investing in advanced research technologies and optimizing its patient recruitment pipelines, the company aims to solidify its reputation as a premier partner for late-stage clinical development. Future efforts will likely focus on scaling operational capacity to meet the increasing demand for specialized, high-integrity research services in an evolving healthcare landscape.
See full New Phase Research & Development company page
